top of page

2010 JAMA Report Cites HRT Cancer Risks

Oct. 20, 2010 The new JAMA report released October 19, 2010 indicates in their study that taking HRT drugs increases the chances of death by 50 percent. HRT drugs are still on the market but who would take this risk? This newest 2010 JAMA  report cites HRT increases cancer risks and has some new and startling information for menopausal women and the risk of getting breast cancer.

Menopause seems to be considered some sort of disease these days and it is not. Menopause is a change of life and perfectly natural and normal progression as a woman ages. Menopause begins usually with mild symptoms in the late 40s or early 50s of a woman’s life. It is a time to turn down the hormones that produce babies but it is not a time to take high risk drugs that will likely kill you.

Historically now for 8 years since the 2002 NIH study, scientific proof exists that HRT a combination of estrogen and progesterone causes cancer in women. Menopausal women are especially targeted in advertising, promotions, doctors approvals to take HRT drugs to relieve hot flashes and other menopause symptoms.

The difference between natural estrogen and synthetic estrogen or manufactured estrogen from pregnant horses is the key to conflicting data. The drug company Wyeth contends that they are one and the same however what is made by naturally by a woman’s body is unique and cannot be duplicated in a laboratory.

The JAMA Findings- Released October 19, 2010

The Journal of American Medical Association JAMA, looked at 11 years of data after the NIH study revealed the findings of more than 12,000 menopausal women.

The new study is a follow up study that included postmenopausal women were age 50 to 70 and were studied at 40 clinics across the United States.

The study concentrated on the death rate or breast cancer mortality and the findings are:

The women who took HRT drugs which is a combination of estrogen and progesterone were twice as likely or had a 50 percent higher risk of death.

The researchers indicated that the HRT drug increased the chances of invasive breast cancer and that the increased proportion of women had cancer that had spread to their lymph nodes. In these cases this is indicative of a very aggressive cancer that spreads throughout the woman’s body.

The report urges caution in the current HRT policies in that HRT drugs are still being sold to women and prescribed by doctors although the evidence of risk at 50 percent would require a change in HRT drugs and removing them from the market.

The researchers wrote “the adverse influence of estrogen plus estrogen on breast cancer mortality in the United States maybe anticipated as well”.

After the 2002 NIH study was halted women stopped using HRT drugs in greater numbers which also reduced the incident of women contracting breast cancer as the data shows in reports from 2004 to 2010.

A **Canadian study in September 2010 revealed that internationally in all countries including Canada when the use of HRT drugs were declining the rate of new breast cancers also declined.

Other claims that drug makers have made that HRT drugs reduce the risk of heart attacks is completely disproved by the data in subsequent studies. In fact HRT drugs are found to increase the risk of blood clots, strokes and heart attacks.

The literature on the pro-HRT side indicated in the past that the “benefits of HRT drugs far outweigh the risk of breast cancer”. This is not true today.

The risk of a women spending the rest of her life with breast cancer and the higher likelihood that she would risk her own death for a few uncomfortable menopausal symptoms is far greater now, than what is being told to women about HRT drugs.

The problem remains that drug companies to avoid responsibility and blame are lobbying the FDA to keep this drug on the market. Apparently they have some women hooked on HRT and they refuse to stop taking the drug.

The FDA has not done the research to keep advocating keeping this drug on the market, therefore the fact that the drug is still available is not a testimony that it is safe or that it does not cause breast cancer. In fact FDA approval these days is highly suspiciously influenced by pharmaceutical personnel. Many of the members on the FDA drug approval panel have connections to big drug companies. The FDA approval of HRT drugs is highly suspicious and needs further investigation.

Reprinted from Politico News

bottom of page